News Daily News CAD Common in MitraClip Patients, but When and If to Fix Are Unclear Shelley Wood December 03, 2020
News Conference News PCR London Valves 2020 No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION Shelley Wood November 26, 2020
News Conference News AHA 2020 Elective PCI Appropriateness Not Linked to Outcomes in the VA System Todd Neale November 23, 2020
News Conference News AHA 2020 CTA Doesn’t Add Value in At-Risk Patients Thought to Have ACS Caitlin E. Cox November 20, 2020
News Conference News ‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III Shelley Wood November 19, 2020
News Conference News AHA 2020 Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS Michael O'Riordan November 14, 2020
News Daily News PCI at Ambulatory Centers: More Bleeding but No Penalty in Overall Outcomes Caitlin E. Cox November 11, 2020
News Opinion Conversations in Cardiology Conversations in Cardiology: How to Juggle Two STEMIs at the Same Time November 09, 2020
News Daily News H. Pylori in ACS: Could Tests and Treatment Beat Back the Bleeds? Shelley Wood November 05, 2020
News Daily News Use of Culprit vs Multivessel PCI for STEMI Tracks With Trial Results Todd Neale November 04, 2020
News Daily News Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5 Michael O'Riordan November 03, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2020 Shelley Wood October 30, 2020
News Daily News Superiority of Ticagrelor Over Clopidogrel in ACS Questioned Todd Neale October 29, 2020
News Daily News Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut Michael O'Riordan October 28, 2020
News Conference News TCT 2020 Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care L.A. McKeown October 26, 2020
News Daily News More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis Michael O'Riordan October 23, 2020
News Conference News TCT 2020 Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up Michael O'Riordan October 23, 2020